To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MTA3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
379 supporting clones for gene MTA3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CR598284 Placenta Cot 25-normalized MTA3.a 1 to 1679 1 to 1679 exact tiling clone,   1679/1679
(100 %)
0 diff
(100 %id)
AL543402 placenta, Placenta Cot 25-normalized MTA3.a 1 to 902 1 to 898   fully sequenced,   898/898
(100 %)
0 diff
(100 %id)
CR619018 T cells (Jurkat cell line) Cot10-normalized MTA3.a 11 to 1683 1 to 1673       1673/1673
(100 %)
0 diff
(100 %id)
BX358619 Placenta Cot 25-normalized MTA3.a 657 to 1671 1016 to 1       1016/1091
(93 %)
25 diff
(97.8 %id)
AL580148 T cells from T cell leukemia MTA3.a 774 to 1651 910 to 32       879/910
(96 %)
0 diff
(100 %id)
BX369410   MTA3.a 840 to 1672 1 to 833       833/836
(99 %)
14 diff
(98.4 %id)
AL570021 placenta, Placenta Cot 25-normalized MTA3.a 872 to 1679 807 to 1   fully sequenced,   807/807
(100 %)
3 diff
(99.7 %id)
TI_149299793   MTA3.a 875 to 1707 900 to 83   AAA   818/944
(86 %)
30 diff
(96.9 %id)
BG196778   MTA3.a 955 to 1716 1 to 761       761/765
(99 %)
28 diff
(96.4 %id)
BG215067   MTA3.a 959 to 1677 1 to 722       722/778
(92 %)
36 diff
(95.4 %id)
BG184400   MTA3.a 960 to 1681 1 to 717       717/786
(91 %)
40 diff
(95.0 %id)
BG189688   MTA3.a 960 to 1711 1 to 751       751/751
(100 %)
6 diff
(99.3 %id)
BG215605   MTA3.a 960 to 1742 1 to 785       785/785
(100 %)
13 diff
(98.4 %id)
BG221202   MTA3.a 960 to 1743 1 to 785       785/785
(100 %)
21 diff
(97.4 %id)
BG184399   MTA3.a 961 to 1740 1 to 776       776/777
(99 %)
15 diff
(98.1 %id)
BU684975 lung, Primary Lung Cystic Fibrosis EpithelialCells MTA3.a 963 to 1707 759 to 19   AAA   741/749
(98 %)
4 diff
(99.5 %id)
BU634131 cell lines, Chondrosarcoma MTA3.a 972 to 1707 755 to 19   AAA   737/737
(100 %)
5 diff
(99.4 %id)
BX107754 heart MTA3.a 1002 to 1689 1 to 688       688/688
(100 %)
2 diff
(99.8 %id)
AF086450   MTA3.a 1002 to 1709 1 to 708   AAA   708/708
(100 %)
0 diff
(100 %id)
BG216235   MTA3.a 1028 to 1671 73 to 712   AAA   640/747
(85 %)
39 diff
(94.8 %id)
BF056179 pooled MTA3.a 1137 to 1706 570 to 1       570/570
(100 %)
0 diff
(100 %id)
AI342393 uterus MTA3.a 1161 to 1708 548 to 1       548/548
(100 %)
0 diff
(100 %id)
AW000846 colon, colonic mucosa from 3 patients with Crohn'sdisease MTA3.a 1170 to 1708 547 to 5       543/760
(71 %)
10 diff
(98.7 %id)
W80850 heart MTA3.a 1177 to 1401 1 to 225   fully sequenced,   225/225
(100 %)
0 diff
(100 %id)
AA868851   MTA3.a 1179 to 1708 534 to 5       530/534
(99 %)
2 diff
(99.7 %id)
AL529243 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized MTA3.a 1189 to 1522 1 to 334   fully sequenced,   334/334
(100 %)
1 diff
(99.8 %id)
AI284172 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MTA3.a 1194 to 1710 529 to 11       519/529
(98 %)
1 diff
(99.9 %id)
AI660356 thymus, pooled MTA3.a 1194 to 1709 534 to 19   AAA   516/516
(100 %)
6 diff
(98.9 %id)
AI127472 heart MTA3.a 1200 to 1713 514 to 1       514/514
(100 %)
2 diff
(99.7 %id)
AI052453 liver and spleen MTA3.a 1259 to 1708 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AA251766 germinal center B cell MTA3.a 1269 to 1707 436 to 1       436/436
(100 %)
9 diff
(98.0 %id)
AI076657 liver and spleen MTA3.a 1271 to 1707 437 to 1       437/437
(100 %)
0 diff
(100 %id)
W80427 heart MTA3.a 1280 to 1710 443 to 6       438/448
(97 %)
6 diff
(98.7 %id)
DB512842 testis MTA3.a 1285 to 1707 1 to 422     Submitted on the opposite strand 422/422
(100 %)
3 diff
(99.3 %id)
TI_154109160   MTA3.a 1286 to 2039 857 to 105   AAA   753/962
(78 %)
11 diff
(98.9 %id)
AI078528   MTA3.a 1287 to 1713 438 to 12   AAA   427/427
(100 %)
1 diff
(99.8 %id)
AW966403   MTA3.a 1306 to 1707 1 to 402       402/571
(70 %)
1 diff
(99.9 %id)
W80761 heart MTA3.a 1340 to 1707 377 to 1   fully sequenced,   377/377
(100 %)
6 diff
(98.5 %id)
BM993279 lung, Metastatic Chondrosarcoma MTA3.a 1352 to 2039 707 to 19   tiling clone, AAA   689/689
(100 %)
4 diff
(99.5 %id)
CA447673 Chondrosarcoma, Left Pelvis MTA3.a 1369 to 2039 690 to 19   tiling clone, AAA   672/676
(99 %)
3 diff
(99.6 %id)
BX471768.
matches multiple genes
  MTA3.a 1453 to 2039 600 to 13   AAA also hits gene snulo 588/588
(100 %)
4 diff
(99.4 %id)
AL529242 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized MTA3.a 1492 to 1676 185 to 1   fully sequenced,   185/185
(100 %)
4 diff
(97.9 %id)
AB033092 brain MTA3.b 1 to 5483 1 to 5484 exact tiling clone, available from KIAA,   5484/5484
(100 %)
1 diff
(100.0 %id)
DB023223 testis MTA3.b 68 to 613 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA781192 brain MTA3.b 125 to 689 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
W85824 liver and spleen MTA3.b 3994 to 4461 1 to 476       476/478
(99 %)
16 diff
(96.7 %id)
DA426735 colon MTA3.b 3996 to 4553 2 to 558   capped   557/557
(100 %)
3 diff
(99.5 %id)
AW163355 brain, frontal lobe MTA3.b 4012 to 4461 1 to 451   fully sequenced,   451/451
(100 %)
2 diff
(99.6 %id)
BU177361 melanotic melanoma, skin MTA3.b 4101 to 4835 11 to 751       741/839
(88 %)
10 diff
(98.9 %id)
BM707674 eye, RPE and Choroid MTA3.b 4425 to 4719 1 to 295       295/295
(100 %)
0 diff
(100 %id)
AW157299 brain, frontal lobe MTA3.b 4431 to 4779 349 to 1   fully sequenced,   349/349
(100 %)
1 diff
(99.8 %id)
BF794268 lymph, lymphoma, cell line MTA3.b 4530 to 5319 29 to 814       786/897
(87 %)
28 diff
(96.9 %id)
BF794262 lymph, lymphoma, cell line MTA3.b 4530 to 5391 28 to 882   tiling clone,   855/1013
(84 %)
41 diff
(96.0 %id)
W21929 eye, retina MTA3.b 4626 to 5178 601 to 65       537/632
(84 %)
0 diff
(100 %id)
TI_157596031   MTA3.b 4905 to 5482 683 to 107   AAA   577/746
(77 %)
14 diff
(98.2 %id)
AW300800 colon, moderately differentiated adenocarcinoma MTA3.b 4999 to 5484 486 to 1   tiling clone,   486/486
(100 %)
0 diff
(100 %id)
AW008498 thymus, pooled MTA3.b 5000 to 5483 490 to 6       485/490
(98 %)
0 diff
(100 %id)
AA704967 liver and spleen MTA3.b 5001 to 5483 483 to 1       483/483
(100 %)
0 diff
(100 %id)
AI566776 anaplastic oligodendroglioma, brain MTA3.b 5011 to 5483 474 to 2       473/474
(99 %)
0 diff
(100 %id)
W72633 heart MTA3.b 5018 to 5483 494 to 15   AAA   480/481
(99 %)
17 diff
(96.5 %id)
AI955865 adenocarcinoma, Pancreas MTA3.b 5022 to 5482 470 to 9       462/470
(98 %)
0 diff
(100 %id)
AW292870   MTA3.b 5022 to 5484 478 to 18   AAA   461/461
(100 %)
3 diff
(99.4 %id)
BU733211 eye, RPE and Choroid MTA3.b 5046 to 5482 455 to 19   AAA   437/437
(100 %)
0 diff
(100 %id)
W85825 liver and spleen MTA3.b 5063 to 5483 426 to 1       426/433
(98 %)
4 diff
(99.1 %id)
AI637497 pooled germ cell tumors MTA3.b 5089 to 5483 394 to 1       394/394
(100 %)
3 diff
(99.3 %id)
AI970515 pooled germ cell tumors MTA3.b 5089 to 5483 396 to 1       396/396
(100 %)
2 diff
(99.5 %id)
BF056849 pooled germ cell tumors MTA3.b 5089 to 5483 395 to 1       395/395
(100 %)
0 diff
(100 %id)
AW270719 brain, three pooled meningiomas MTA3.b 5103 to 5482 380 to 1       380/380
(100 %)
0 diff
(100 %id)
AI139323 uterus MTA3.b 5152 to 5483 333 to 2       332/333
(99 %)
0 diff
(100 %id)
AW769522 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney MTA3.b 5159 to 5483 344 to 20   AAA   325/326
(99 %)
8 diff
(97.6 %id)
AI634473 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors MTA3.b 5161 to 5483 323 to 2       322/323
(99 %)
0 diff
(100 %id)
AA102083 uterus MTA3.b 5191 to 5483 293 to 1       293/293
(100 %)
0 diff
(100 %id)
DB478165 hippocampus MTA3.c 1 to 491 1 to 491   tiling clone,   491/491
(100 %)
1 diff
(99.8 %id)
AK127245 hippocampus MTA3.c 356 to 6186 1 to 5831 exact tiling clone, available from FLJ,   5831/5831
(100 %)
8 diff
(99.9 %id)
DA239202 brain MTA3.c 357 to 888 2 to 533   capped   532/571
(93 %)
2 diff
(99.7 %id)
DA314866 hippocampus MTA3.c 357 to 799 2 to 444   capped   443/443
(100 %)
5 diff
(98.9 %id)
DB441941 testis MTA3.c 431 to 859 1 to 429       429/429
(100 %)
8 diff
(98.2 %id)
DB461896 testis MTA3.c 431 to 912 1 to 482       482/482
(100 %)
1 diff
(99.8 %id)
DA333467 hippocampus MTA3.c 451 to 1024 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DB447727 testis MTA3.c 466 to 894 1 to 429       429/446
(96 %)
6 diff
(98.7 %id)
DB096888 testis MTA3.c 477 to 1027 2 to 552   tiling clone, capped   551/551
(100 %)
0 diff
(100 %id)
DA336424 hippocampus MTA3.c 865 to 1437 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BG010137 placenta_normal MTA3.c 882 to 1465 15 to 597       583/603
(96 %)
27 diff
(95.6 %id)
BG010139 placenta_normal MTA3.c 882 to 1457 14 to 589       576/589
(97 %)
26 diff
(95.6 %id)
FN117324 breast carcinoma MTA3.c 884 to 953 13 to 82       70/84
(83 %)
1 diff
(98.9 %id)
BE274374 melanotic melanoma, skin MTA3.c 886 to 1566 9 to 690       682/925
(73 %)
16 diff
(98.3 %id)
BM793613 Ascites, stomach MTA3.c 907 to 1298 16 to 407       392/407
(96 %)
9 diff
(97.8 %id)
BM014312 breast, mammary adenocarcinoma, cell line MTA3.c 941 to 1539 1 to 603       601/612
(98 %)
9 diff
(98.6 %id)
TI_59392325   MTA3.c 941 to 1539 97 to 699       601/612
(98 %)
9 diff
(98.6 %id)
CB992331 placenta, pre-eclamptic placenta MTA3.c 1001 to 1789 23 to 815       793/816
(97 %)
16 diff
(98.1 %id)
CD652670 Embryonic Stem cells MTA3.c 1008 to 1738 12 to 740       729/805
(90 %)
11 diff
(98.7 %id)
CB143556 Liver MTA3.c 1020 to 1495 1 to 476       476/476
(100 %)
0 diff
(100 %id)
DN602122 human embryonic stem cells MTA3.c 1112 to 1809 13 to 710       698/710
(98 %)
7 diff
(99.1 %id)
AA169366   MTA3.c 1122 to 1600 7 to 489       483/489
(98 %)
9 diff
(98.2 %id)
BG149449 carcinoid, lung MTA3.c 1147 to 1847 1 to 701     Submitted on the opposite strand 701/701
(100 %)
7 diff
(99.1 %id)
AA149565 colon, tumor MTA3.c 1208 to 1748 1 to 537       537/579
(92 %)
5 diff
(99.2 %id)
BF920681 nervous_tumor MTA3.c 1241 to 1507 275 to 14     Submitted on the opposite strand 265/285
(92 %)
0 diff
(100 %id)
CX788254 human embryonic stem cells MTA3.c 1271 to 2007 19 to 755       737/755
(97 %)
6 diff
(99.3 %id)
BQ319210 colon MTA3.c 1313 to 1589 304 to 28       277/304
(91 %)
0 diff
(100 %id)
BE812221 amnion_normal MTA3.c 1354 to 1763 1 to 410       410/410
(100 %)
2 diff
(99.6 %id)
FN088313 breast carcinoma MTA3.c 1357 to 1446 88 to 2     Submitted on the opposite strand 87/103
(84 %)
0 diff
(100 %id)
BE812319 amnion_normal MTA3.c 1366 to 1860 1 to 499       498/499
(99 %)
22 diff
(95.6 %id)
BF666656 brain, primitive neuroectoderm MTA3.c 1368 to 2110 1 to 724       724/884
(81 %)
27 diff
(97.0 %id)
BM474107 leiomyosarcoma, uterus MTA3.c 1381 to 2314 1 to 942       942/962
(97 %)
14 diff
(98.6 %id)
CN357567 embryonic stem cells, cell lines H1, H7, andH9 MTA3.c 1384 to 1765 1 to 382       382/382
(100 %)
2 diff
(99.5 %id)
BQ311911 breast_normal MTA3.c 1406 to 1527 1 to 122       122/122
(100 %)
2 diff
(98.4 %id)
BF927251 nervous_tumor MTA3.c 1440 to 1641 8 to 211       204/211
(96 %)
21 diff
(90.1 %id)
DB060368 testis MTA3.c 1446 to 1996 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BF935231 nervous_tumor MTA3.c 1514 to 1861 352 to 2     Submitted on the opposite strand 349/352
(99 %)
2 diff
(99.5 %id)
CN357560 embryonic stem cells, cell lines H1, H7, andH9 MTA3.c 1589 to 2270 1 to 682       682/682
(100 %)
0 diff
(100 %id)
FN087687 breast carcinoma MTA3.c 1591 to 1662 72 to 1     Submitted on the opposite strand 72/72
(100 %)
4 diff
(94.5 %id)
DA233385 brain MTA3.c 1620 to 2205 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
BF816891 colon_ins MTA3.c 1694 to 1882 20 to 208       189/215
(87 %)
12 diff
(94.5 %id)
BE566922 bladder, carcinoma, cell line MTA3.c 1694 to 2340 1 to 651       651/651
(100 %)
16 diff
(97.6 %id)
BE925927 breast_normal MTA3.c 1749 to 2062 322 to 14       309/335
(92 %)
2 diff
(99.5 %id)
FN100080 breast carcinoma MTA3.c 1768 to 1856 88 to 1     Submitted on the opposite strand 88/91
(96 %)
4 diff
(95.7 %id)
FN119123 breast carcinoma MTA3.c 1768 to 1856 88 to 1     Submitted on the opposite strand 88/91
(96 %)
1 diff
(99.0 %id)
AI684083 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors MTA3.c 1768 to 2378 606 to 1       607/607
(100 %)
10 diff
(98.4 %id)
CR738742 heart MTA3.c 1788 to 2364 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
W80557 heart MTA3.c 1788 to 2157 1 to 374       374/426
(87 %)
5 diff
(98.9 %id)
CA396914 eye, RPE/choroid MTA3.c 1810 to 2422 1 to 613       613/613
(100 %)
0 diff
(100 %id)
AA648497 germinal center B cell MTA3.c 1884 to 2378 494 to 1       494/494
(100 %)
3 diff
(99.4 %id)
AA151645 colon, tumor MTA3.c 1885 to 2378 488 to 1       488/512
(95 %)
18 diff
(96.5 %id)
DA510361 brain MTA3.c 1900 to 2485 2 to 587   capped   586/587
(99 %)
3 diff
(99.5 %id)
AW771357 colon, juvenile granulosa tumor MTA3.c 1926 to 2378 453 to 1       453/453
(100 %)
7 diff
(98.5 %id)
AI292310 placenta MTA3.c 1965 to 2363 399 to 1       399/399
(100 %)
5 diff
(98.8 %id)
AI560222 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors MTA3.c 1970 to 2378 409 to 1       409/414
(98 %)
0 diff
(100 %id)
AW803042 uterus MTA3.c 1979 to 2241 1 to 264       264/264
(100 %)
3 diff
(98.9 %id)
DA803363 brain MTA3.c 2004 to 2553 2 to 551   capped   550/550
(100 %)
2 diff
(99.7 %id)
AA879218 metastatic prostate bone lesion MTA3.c 2021 to 2375 8 to 362       355/365
(97 %)
12 diff
(96.8 %id)
AA663292   MTA3.c 2025 to 2378 358 to 1       358/358
(100 %)
8 diff
(97.8 %id)
DA327341 hippocampus MTA3.c 2044 to 2603 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
AA832190 germinal center B cell MTA3.c 2055 to 2378 325 to 1       325/325
(100 %)
4 diff
(98.8 %id)
AA383427 testis MTA3.c 2064 to 2337 1 to 274       274/274
(100 %)
0 diff
(100 %id)
BE645462 Prostate MTA3.c 2104 to 2379 276 to 1       276/276
(100 %)
9 diff
(96.8 %id)
AA661682 alveolar rhabdomyosarcoma MTA3.c 2113 to 2312 203 to 4       200/203
(98 %)
5 diff
(97.6 %id)
DA327527 hippocampus MTA3.c 2120 to 2685 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA406336 thalamus MTA3.c 2166 to 2733 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA406359 thalamus MTA3.c 2166 to 2743 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA093725 cerebellum MTA3.c 2179 to 2715 2 to 537   capped   536/536
(100 %)
2 diff
(99.7 %id)
AI143295 heart MTA3.c 2196 to 2283 88 to 1       88/88
(100 %)
3 diff
(96.6 %id)
FN172609 breast carcinoma MTA3.c 2261 to 2332 1 to 72       72/72
(100 %)
3 diff
(95.9 %id)
DB093707 testis MTA3.c 2286 to 2837 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
AL161954 testis MTA3.c 2307 to 6186 1 to 3880   tiling clone, available from DKFZ, AAA   3880/3880
(100 %)
4 diff
(99.9 %id)
AW902879 nervous_normal MTA3.c 2316 to 2539 12 to 236       225/240
(93 %)
9 diff
(96.3 %id)
DA437959 tongue, tumor tissue MTA3.c 2378 to 2802 145 to 570   capped   426/569
(74 %)
6 diff
(99.0 %id)
DB161165 thymus MTA3.c 2393 to 2958 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
AW815902 stomach MTA3.c 2394 to 2570 21 to 196       176/202
(87 %)
11 diff
(94.6 %id)
DA326030 hippocampus MTA3.c 2454 to 2918 2 to 467   capped   466/466
(100 %)
1 diff
(99.8 %id)
DA801616 brain MTA3.c 2517 to 2984 2 to 469   capped   468/468
(100 %)
1 diff
(99.8 %id)
AI024810   MTA3.c 2700 to 3123 427 to 4       424/427
(99 %)
0 diff
(100 %id)
DA408020 thalamus MTA3.c 2736 to 3275 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DA313022 hippocampus MTA3.c 2737 to 3279 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DB085825 testis MTA3.c 2737 to 3260 2 to 526   capped   525/525
(100 %)
3 diff
(99.5 %id)
DA196410 amygdala MTA3.c 2738 to 3302 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA189165 amygdala MTA3.c 2739 to 3260 2 to 524   capped   523/523
(100 %)
1 diff
(99.9 %id)
DA223765 brain MTA3.c 2739 to 3303 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA406202 thalamus MTA3.c 2739 to 3247 2 to 510   capped   509/509
(100 %)
0 diff
(100 %id)
DA414971 thalamus MTA3.c 2739 to 3302 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA418257 thalamus MTA3.c 2739 to 3280 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
DA503262 brain MTA3.c 2739 to 3292 2 to 558   capped   557/557
(100 %)
4 diff
(99.3 %id)
AW502404 lymph MTA3.c 2773 to 3266 1 to 494       494/494
(100 %)
5 diff
(99.0 %id)
TI_154157710   MTA3.c 2778 to 3392 78 to 692       615/622
(98 %)
19 diff
(97.0 %id)
AI653248 pooled germ cell tumors MTA3.c 2812 to 3310 500 to 1       500/500
(100 %)
1 diff
(99.8 %id)
BF056776 pooled germ cell tumors MTA3.c 2890 to 3310 422 to 1       422/422
(100 %)
5 diff
(98.9 %id)
DA123508 cerebellum MTA3.c 2917 to 3462 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
AW449627   MTA3.c 3016 to 3310 313 to 18   AAA   296/296
(100 %)
1 diff
(99.7 %id)
DA152955 amygdala MTA3.c 3085 to 3624 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
AW504603 lymph MTA3.c 3089 to 3504 8 to 423       416/423
(98 %)
6 diff
(98.6 %id)
TI_154160804   MTA3.c 3089 to 3652 85 to 649       565/565
(100 %)
17 diff
(97.0 %id)
AW975632   MTA3.c 3092 to 3406 432 to 118     Submitted on the opposite strand 315/553
(56 %)
0 diff
(100 %id)
AA730413 Ewing's sarcoma MTA3.c 3120 to 3406 291 to 7       285/291
(97 %)
0 diff
(100 %id)
DA301013 hippocampus MTA3.c 3165 to 3725 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
DA790875 brain MTA3.c 3182 to 3657 2 to 477   capped   476/476
(100 %)
2 diff
(99.6 %id)
DA483189 brain MTA3.c 3192 to 4002 2 to 815   capped   814/815
(99 %)
6 diff
(99.3 %id)
CN357558 embryonic stem cells, cell lines H1, H7, andH9 MTA3.c 3292 to 3880 1 to 589       589/589
(100 %)
2 diff
(99.7 %id)
M79071   MTA3.c 3322 to 3540 1 to 219       219/219
(100 %)
0 diff
(100 %id)
DA501378 brain MTA3.c 3324 to 3890 2 to 568   capped   567/569
(99 %)
1 diff
(99.9 %id)
BQ069011 brain, neuroblastoma, cell line MTA3.c 3335 to 4260 1 to 931       931/1023
(91 %)
23 diff
(97.8 %id)
BQ948758 brain, neuroblastoma, cell line MTA3.c 3335 to 4194 1 to 862       862/878
(98 %)
8 diff
(99.1 %id)
BF907661 uterus_tumor MTA3.c 3354 to 3897 544 to 1     Submitted on the opposite strand 544/544
(100 %)
3 diff
(99.5 %id)
BX488246   MTA3.c 3413 to 3899 1 to 487       487/487
(100 %)
1 diff
(99.8 %id)
DA527632 brain MTA3.c 3414 to 3994 2 to 582   capped   581/581
(100 %)
4 diff
(99.4 %id)
DA293163 hippocampus MTA3.c 3528 to 4078 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA911237   MTA3.c 3530 to 4075 2 to 547   capped   546/546
(100 %)
2 diff
(99.7 %id)
DA083257 cerebellum MTA3.c 3651 to 4180 2 to 531   tiling clone, capped   530/530
(100 %)
1 diff
(99.9 %id)
DA057045 cerebellum MTA3.c 3699 to 4060 2 to 363   capped   362/362
(100 %)
0 diff
(100 %id)
BQ722443 sympathetic trunk MTA3.c 3926 to 4642 1 to 722       722/966
(74 %)
20 diff
(98.0 %id)
BF847707 lung_normal MTA3.c 4299 to 4568 302 to 34     Submitted on the opposite strand 269/302
(89 %)
0 diff
(100 %id)
DA357264 subthalamic nucleus MTA3.c 4403 to 4977 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
BP424747 small intestine MTA3.c 4475 to 4975 1 to 501     Submitted on the opposite strand 501/501
(100 %)
0 diff
(100 %id)
DT217373 brain MTA3.c 4572 to 5149 1 to 578   tiling clone,   578/578
(100 %)
1 diff
(99.9 %id)
Z44650 brain, total brain MTA3.c 4598 to 4937 1 to 339       339/339
(100 %)
4 diff
(98.9 %id)
DB308704 hippocampus MTA3.c 5632 to 6186 555 to 1       555/555
(100 %)
6 diff
(99.0 %id)
Z40506 brain, total brain MTA3.c 5916 to 6186 271 to 1       271/271
(100 %)
2 diff
(99.3 %id)
BU859486 ovary, teratocarcinoma, cell line MTA3.d 1 to 819 1 to 829   tiling clone,   829/907
(91 %)
22 diff
(97.6 %id)
BC053631 Uterus, leiomyosarcoma MTA3.d 15 to 1870 1 to 1856   tiling clone, available from MGC, AAA   1856/1856
(100 %)
3 diff
(99.9 %id)
NM_020744.2   MTA3.d 15 to 1870 1 to 1856   RefSeq, AAA   1856/1856
(100 %)
3 diff
(99.9 %id)
BQ959631 leiomyosarcoma, uterus MTA3.d 16 to 931 1 to 916       916/926
(98 %)
15 diff
(98.4 %id)
DR760932 embryonic stem MTA3.d 110 to 930 1 to 821       821/821
(100 %)
5 diff
(99.4 %id)
DA587823 lung MTA3.d 117 to 418 2 to 303   capped   302/302
(100 %)
0 diff
(100 %id)
BQ892992 dorsal root ganglia MTA3.d 121 to 735 1 to 619       619/776
(79 %)
27 diff
(96.6 %id)
CR597627 B cells (Ramos cell line) Cot 25-normalized MTA3.d 125 to 1856 1 to 1732       1732/1732
(100 %)
0 diff
(100 %id)
BX367228   MTA3.d 125 to 1059 1 to 928   fully sequenced,   928/928
(100 %)
2 diff
(99.8 %id)
CN357563 embryonic stem cells, cell lines H1, H7, andH9 MTA3.d 136 to 813 1 to 679       679/679
(100 %)
2 diff
(99.8 %id)
CN357570 embryonic stem cells, cell lines H1, H7, andH9 MTA3.d 139 to 836 1 to 698       698/698
(100 %)
1 diff
(99.9 %id)
BU595062 mixed (pool of 40 RNAs) MTA3.d 168 to 931 1 to 764       764/819
(93 %)
14 diff
(98.3 %id)
AL558286 T cells from T cell leukemia MTA3.d 169 to 1141 1 to 968       968/968
(100 %)
15 diff
(98.5 %id)
CN357557 embryonic stem cells, cell lines H1, H7, andH9 MTA3.d 171 to 557 44 to 430       387/430
(90 %)
6 diff
(98.7 %id)
CN357566 embryonic stem cells, cell lines H1, H7, andH9 MTA3.d 171 to 806 13 to 648       636/648
(98 %)
7 diff
(99.0 %id)
BC004227 Lymph, Burkitt lymphoma MTA3.d 173 to 1870 1 to 1698   available from MGC, AAA   1698/1698
(100 %)
0 diff
(100 %id)
CN357562 embryonic stem cells, cell lines H1, H7, andH9 MTA3.d 175 to 933 1 to 759       759/760
(99 %)
2 diff
(99.8 %id)
CN357559 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MTA3.d 177 to 809 1 to 633       633/633
(100 %)
0 diff
(100 %id)
CN357568 embryonic stem cells, DMSO-treated H9 cellline MTA3.d 177 to 764 9 to 597       589/597
(98 %)
7 diff
(98.9 %id)
DA523860 brain MTA3.d 187 to 762 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
CN357569 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MTA3.d 194 to 931 11 to 749       739/753
(98 %)
8 diff
(99.0 %id)
DA396298 thalamus MTA3.d 197 to 784 2 to 589   capped   588/588
(100 %)
2 diff
(99.7 %id)
DA996770   MTA3.d 200 to 715 2 to 517   capped   516/516
(100 %)
1 diff
(99.9 %id)
DA202979 brain MTA3.d 201 to 770 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA739646   MTA3.d 201 to 710 2 to 511   capped   510/510
(100 %)
0 diff
(100 %id)
AK027304 whole embryo, mainly head MTA3.d 203 to 1870 1 to 1668   available from FLJ,   1668/1668
(100 %)
1 diff
(100.0 %id)
DA569817 whole embryo, mainly head MTA3.d 204 to 882 2 to 678   capped   677/677
(100 %)
2 diff
(99.8 %id)
BG431955 Kidney MTA3.d 204 to 717 1 to 514       514/514
(100 %)
1 diff
(99.9 %id)
DA864209 placenta MTA3.d 204 to 803 2 to 601   capped   600/600
(100 %)
0 diff
(100 %id)
DB118186 thymus MTA3.d 208 to 773 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA158787 amygdala MTA3.d 213 to 721 2 to 510   capped   509/509
(100 %)
0 diff
(100 %id)
DA322636 hippocampus MTA3.d 213 to 755 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DB220094 trachea MTA3.d 215 to 764 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
AL546619 placenta, Placenta Cot 25-normalized MTA3.d 217 to 1236 1 to 1013       1013/1013
(100 %)
17 diff
(98.4 %id)
CD693430 normal nasopharynx MTA3.d 218 to 763 24 to 569       546/569
(95 %)
7 diff
(98.8 %id)
CD705946 normal nasopharynx MTA3.d 218 to 648 15 to 444       430/444
(96 %)
9 diff
(98.0 %id)
BG703625 brain, hippocampus MTA3.d 219 to 1027 1 to 811       811/811
(100 %)
22 diff
(97.3 %id)
CN357556 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MTA3.d 220 to 733 1 to 513       513/513
(100 %)
4 diff
(99.3 %id)
CR612595 Placenta Cot 25-normalized MTA3.d 225 to 1838 1 to 1614       1614/1614
(100 %)
0 diff
(100 %id)
AL543832 placenta, Placenta Cot 25-normalized MTA3.d 225 to 1151 1 to 926   fully sequenced,   926/926
(100 %)
2 diff
(99.8 %id)
BF751577 breast_normal MTA3.d 226 to 598 39 to 415       375/415
(90 %)
27 diff
(93.5 %id)
AL709792 human skeletal muscle MTA3.d 226 to 779 1 to 554       554/554
(100 %)
1 diff
(99.9 %id)
BI561011 testis MTA3.d 226 to 1095 1 to 866       866/867
(99 %)
27 diff
(96.9 %id)
DA338199 hippocampus MTA3.d 227 to 818 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
TI_1948085765   MTA3.d 229 to 1032 130 to 943   fully sequenced,   814/943
(86 %)
18 diff
(98.1 %id)
TI_1948085911   MTA3.d 229 to 1077 124 to 979   fully sequenced, Submitted on the opposite strand 856/979
(87 %)
13 diff
(98.7 %id)
TI_1948086230   MTA3.d 229 to 1048 122 to 940     Submitted on the opposite strand 819/1366
(59 %)
19 diff
(98.7 %id)
CV026177 mixed MTA3.d 230 to 831 1 to 602       602/603
(99 %)
1 diff
(99.9 %id)
TI_44349246   MTA3.d 230 to 1095 123 to 984       862/985
(87 %)
30 diff
(97.0 %id)
TI_1948086076   MTA3.d 230 to 1120 123 to 1018     Submitted on the opposite strand 896/1317
(68 %)
39 diff
(97.1 %id)
TI_159698350   MTA3.d 230 to 1120 62 to 943     Submitted on the opposite strand 882/1104
(79 %)
33 diff
(97.1 %id)
CN357561 embryonic stem cells, cell lines H1, H7, andH9 MTA3.d 231 to 868 1 to 638       638/638
(100 %)
1 diff
(99.9 %id)
CN357565 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells MTA3.d 235 to 945 1 to 711       711/711
(100 %)
0 diff
(100 %id)
BQ953592 leiomyosarcoma, uterus MTA3.d 235 to 1120 1 to 889       889/909
(97 %)
7 diff
(99.3 %id)
CX784165 human embryonic stem cells MTA3.d 242 to 949 1 to 708       708/708
(100 %)
0 diff
(100 %id)
BE299307 muscle, rhabdomyosarcoma MTA3.d 244 to 931 22 to 714       693/862
(80 %)
19 diff
(97.8 %id)
BI088078 cervix MTA3.d 244 to 1022 1 to 780       780/788
(98 %)
16 diff
(98.0 %id)
BG661047   MTA3.d 246 to 942 1 to 698       698/698
(100 %)
2 diff
(99.8 %id)
DN990752 brain, whole brain MTA3.d 247 to 729 8 to 490       483/504
(95 %)
1 diff
(99.9 %id)
TI_57228504   MTA3.d 419 to 1271 50 to 907       858/858
(100 %)
13 diff
(98.5 %id)
BI870768 adenocarcinoma, cell line, Liver MTA3.d 421 to 1271 1 to 856       856/856
(100 %)
13 diff
(98.5 %id)
BU500841 eye, normal pigmented retinal epithelium MTA3.d 620 to 1324 1 to 707       707/861
(82 %)
5 diff
(99.5 %id)
DA242694 brain MTA3.d 712 to 1292 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
BM701624 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid MTA3.d 782 to 1391 1 to 610   fully sequenced,   610/610
(100 %)
1 diff
(99.9 %id)
BE079717 breast MTA3.d 783 to 1282 509 to 10     Submitted on the opposite strand 500/509
(98 %)
3 diff
(99.5 %id)
BE909849 epithelioid carcinoma, Pancreas MTA3.d 853 to 1530 1 to 677       677/941
(71 %)
9 diff
(99.1 %id)
CD701732 normal nasopharynx MTA3.d 933 to 1401 15 to 484       470/484
(97 %)
7 diff
(98.6 %id)
BX476217   MTA3.d 952 to 1430 1 to 479       479/479
(100 %)
0 diff
(100 %id)
TI_1948085766   MTA3.d 1002 to 1779 911 to 123   fully sequenced,   789/911
(86 %)
11 diff
(98.8 %id)
AW007688 colon MTA3.d 1010 to 1801 853 to 62       769/853
(90 %)
44 diff
(94.9 %id)
BX367227   MTA3.d 1029 to 1856 828 to 1   fully sequenced,   828/828
(100 %)
6 diff
(99.3 %id)
BG031060 breast, mammary adenocarcinoma, cell line MTA3.d 1036 to 1834 1 to 797       797/888
(89 %)
19 diff
(97.9 %id)
AA164473   MTA3.d 1043 to 1479 1 to 441       441/441
(100 %)
4 diff
(99.1 %id)
TI_1948085910   MTA3.d 1047 to 1779 863 to 129   fully sequenced, Submitted on the opposite strand 735/863
(85 %)
22 diff
(97.5 %id)
DA109651 cerebellum MTA3.d 1087 to 1615 2 to 532   capped   531/531
(100 %)
3 diff
(99.5 %id)
AL570159 placenta, Placenta Cot 25-normalized MTA3.d 1090 to 1838 749 to 1   fully sequenced,   749/749
(100 %)
24 diff
(96.8 %id)
CB144538 Liver MTA3.d 1091 to 1488 1 to 397       397/397
(100 %)
1 diff
(99.8 %id)
BG212929   MTA3.d 1116 to 1905 1 to 785       785/790
(99 %)
24 diff
(97.0 %id)
BG195923   MTA3.d 1117 to 1736 1 to 618       618/783
(78 %)
14 diff
(98.3 %id)
BG202984   MTA3.d 1117 to 1874 1 to 758       758/761
(99 %)
16 diff
(97.9 %id)
BG213435   MTA3.d 1117 to 1839 1 to 730       730/806
(90 %)
39 diff
(95.2 %id)
BG193810   MTA3.d 1118 to 1881 1 to 765       765/765
(100 %)
13 diff
(98.4 %id)
BG185439   MTA3.d 1119 to 1895 1 to 776       776/778
(99 %)
13 diff
(98.4 %id)
BG217731   MTA3.d 1119 to 1882 1 to 764       764/775
(98 %)
7 diff
(99.1 %id)
AW007683 colon MTA3.d 1121 to 1871 748 to 1       748/787
(95 %)
6 diff
(99.3 %id)
BG199898   MTA3.d 1124 to 1695 82 to 653       572/829
(68 %)
38 diff
(95.5 %id)
AW886478 ovary MTA3.d 1146 to 1359 13 to 226       214/226
(94 %)
6 diff
(97.4 %id)
BE883967 leiomyosarcoma, uterus MTA3.d 1157 to 1832 1 to 670       670/690
(97 %)
15 diff
(97.9 %id)
AW270557 endometrioid ovarian metastasis, ovary MTA3.d 1169 to 1756 40 to 627     Submitted on the opposite strand 588/627
(93 %)
13 diff
(98.0 %id)
TI_154100384   MTA3.d 1176 to 1868 777 to 85   AAA   693/694
(99 %)
0 diff
(100 %id)
BI047872 stomach MTA3.d 1194 to 1427 238 to 6       233/240
(97 %)
1 diff
(99.6 %id)
BE885323 leiomyosarcoma, uterus MTA3.d 1194 to 1779 1 to 602       602/602
(100 %)
22 diff
(96.4 %id)
CA441359 Fibrosarcoma MTA3.d 1196 to 1868 691 to 19   AAA   673/673
(100 %)
0 diff
(100 %id)
TI_1948086229   MTA3.d 1197 to 1779 712 to 129     Submitted on the opposite strand 584/1473
(39 %)
1 diff
(100.0 %id)
AW886477 ovary MTA3.d 1212 to 1359 1 to 149       149/149
(100 %)
8 diff
(94.7 %id)
AW999159 breast_normal MTA3.d 1235 to 1437 3 to 205       203/207
(98 %)
10 diff
(95.2 %id)
AL571907 placenta, Placenta Cot 25-normalized MTA3.d 1274 to 1840 571 to 1       571/597
(95 %)
7 diff
(98.9 %id)
BU738689 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid MTA3.d 1349 to 1870 538 to 17   fully sequenced, AAA   522/522
(100 %)
0 diff
(100 %id)
DB356517 whole embryo, mainly head MTA3.d 1375 to 1870 494 to 1       494/542
(91 %)
5 diff
(99.1 %id)
AA305415 colon MTA3.d 1401 to 1817 8 to 424       417/424
(98 %)
6 diff
(98.6 %id)
AI056219 liver and spleen MTA3.d 1403 to 1869 467 to 1       467/467
(100 %)
0 diff
(100 %id)
BE172424 head_neck MTA3.d 1516 to 1869 361 to 9     Submitted on the opposite strand 353/361
(97 %)
0 diff
(100 %id)
AI057371 liver and spleen MTA3.d 1646 to 1868 234 to 12   AAA   223/227
(98 %)
0 diff
(100 %id)
CN270300 embryonic stem cells, DMSO-treated H9 cellline MTA3.d 1669 to 1868 1 to 200   AAA   200/200
(100 %)
0 diff
(100 %id)
FN050416 breast carcinoma MTA3.d 1712 to 1821 110 to 1     Submitted on the opposite strand 110/110
(100 %)
0 diff
(100 %id)
BM992340 Bone, Subchondral Bone MTA3.d 1768 to 2200 452 to 19   tiling clone, AAA   434/434
(100 %)
3 diff
(99.4 %id)
AA171654   MTA3.d 1769 to 1859 1 to 92   fully sequenced,   92/92
(100 %)
1 diff
(99.0 %id)
AW512740 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus MTA3.d 1778 to 2200 424 to 1       424/424
(100 %)
3 diff
(99.3 %id)
AI624932 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors MTA3.d 1784 to 2202 421 to 2       420/421
(99 %)
0 diff
(100 %id)
AA626185   MTA3.d 1791 to 2202 414 to 2   tiling clone,   413/414
(99 %)
0 diff
(100 %id)
AA169121   MTA3.d 1829 to 2203 380 to 1   tiling clone, fully sequenced,   380/380
(100 %)
5 diff
(98.7 %id)
CR621276 T cells (Jurkat cell line) MTA3.e 1 to 1656 1 to 1656 exact tiling clone,   1656/1656
(100 %)
0 diff
(100 %id)
AL557380 T cells (Jurkat cell line), T cells from T cell leukemia MTA3.e 1 to 845 1 to 841   fully sequenced,   841/841
(100 %)
1 diff
(99.9 %id)
AL579426 T cells (Jurkat cell line), T cells from T cell leukemia MTA3.e 815 to 1656 847 to 1   fully sequenced,   847/847
(100 %)
12 diff
(98.6 %id)
AW946206 lung_tumor MTA3.f 1 to 360 425 to 66   tiling clone, Submitted on the opposite strand 360/425
(84 %)
0 diff
(100 %id)
AW946210 lung_tumor MTA3.f 1 to 345 385 to 36     Submitted on the opposite strand 350/385
(90 %)
0 diff
(100 %id)
DB019561 testis MTA3.f 153 to 854 2 to 703   tiling clone, capped   702/716
(98 %)
4 diff
(99.5 %id)
DB335600 testis MTA3.f 1802 to 2322 518 to 1   tiling clone,   518/524
(98 %)
25 diff
(95.3 %id)
DA834269 placenta MTA3.g 1 to 801 2 to 808   tiling clone, capped   807/807
(100 %)
10 diff
(98.8 %id)
DB381446 placenta MTA3.g 4309 to 4612 320 to 18   tiling clone, AAA   303/303
(100 %)
4 diff
(98.7 %id)
AA506885 Prostate MTA3.h 1 to 382 1 to 381   tiling clone,   381/381
(100 %)
3 diff
(99.3 %id)
BE858185 brain, glioblastoma (pooled) MTA3.h 257 to 815 559 to 1   tiling clone,   559/559
(100 %)
0 diff
(100 %id)
AI422174 brain, glioblastoma (pooled) MTA3.h 283 to 815 533 to 1       533/533
(100 %)
0 diff
(100 %id)
AI359618 brain, glioblastoma (pooled) MTA3.h 338 to 815 478 to 1       478/478
(100 %)
0 diff
(100 %id)
DA228761 brain MTA3.i 1 to 549 2 to 550 exact tiling clone, capped   549/549
(100 %)
0 diff
(100 %id)
AW967256   MTA3.j 1 to 412 1 to 411   tiling clone,   411/529
(77 %)
9 diff
(98.3 %id)
AK122690 amygdala MTA3.j 30 to 2532 1 to 2503 T79A tiling clone, available from FLJ,   2503/2503
(100 %)
12 diff
(99.6 %id)
DA182124 amygdala MTA3.j 31 to 603 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BG623513 placenta MTA3.j 485 to 1124 4 to 638   tiling clone,   635/791
(80 %)
6 diff
(99.3 %id)
CX788833 human embryonic stem cells MTA3.j 850 to 1628 1 to 778   tiling clone,   778/778
(100 %)
2 diff
(99.8 %id)
AA846962 ovary MTA3.j 969 to 1383 1 to 415       415/415
(100 %)
2 diff
(99.6 %id)
CB104620 stomach MTA3.j 995 to 1099 1 to 105       105/105
(100 %)
1 diff
(99.1 %id)
CN273710 embryonic stem cells, DMSO-treated H9 cellline MTA3.j 1170 to 1891 1 to 723   tiling clone,   723/723
(100 %)
1 diff
(99.9 %id)
DA339097 hippocampus MTA3.j 1777 to 2350 2 to 575   tiling clone, capped   574/574
(100 %)
0 diff
(100 %id)
CA412494 Chondrosarcoma Grade II, Left Pelvis MTA3.j 1828 to 2530 721 to 19 exact AAA   703/703
(100 %)
2 diff
(99.8 %id)
DB302950 amygdala MTA3.j 1965 to 2532 568 to 1 T79A R98X     568/568
(100 %)
1 diff
(99.9 %id)
TI_57230325   MTA3.k 1 to 732 82 to 811 L38C S39H R40A Q41S Y42M ... tiling clone,   730/730
(100 %)
4 diff
(99.5 %id)
BI868915 adenocarcinoma, cell line, Liver MTA3.k 2 to 732 1 to 729 L38C S39H R40A Q41S Y42M ... tiling clone,   729/729
(100 %)
4 diff
(99.5 %id)
AL700825 human skeletal muscle MTA3.l 1 to 649 1 to 649 exact     649/649
(100 %)
1 diff
(99.9 %id)
AL699964 human skeletal muscle MTA3.l 1 to 649 1 to 649 exact tiling clone,   649/649
(100 %)
1 diff
(99.9 %id)
BE939365 uterus MTA3.l 251 to 619 1 to 366 I10N E53V     366/366
(100 %)
8 diff
(97.9 %id)
BG201924   MTA3.m 1 to 623 3 to 625 M15T W16V K17E T18N T19Y ... tiling clone, AAA   625/625
(100 %)
6 diff
(99.1 %id)
BG290538 bladder, transitional cell papilloma, cell line MTA3.n 1 to 755 1 to 753 exact tiling clone,   753/889
(84 %)
43 diff
(95.2 %id)
AL703950 human skeletal muscle MTA3.o-u 1 to 585 1 to 585   tiling clone,   585/585
(100 %)
1 diff
(99.9 %id)
AL703966 human skeletal muscle MTA3.o-u 1 to 716 1 to 716       716/716
(100 %)
1 diff
(99.9 %id)
AL704682 human skeletal muscle MTA3.o-u 40 to 249 1 to 207       207/207
(100 %)
3 diff
(98.6 %id)
DB132179 thymus MTA3.o-u 576 to 1103 2 to 529   tiling clone, to resequence, capped   528/528
(100 %)
1 diff
(99.9 %id)
DB140852 thymus MTA3.o-u 922 to 1486 2 to 566   tiling clone, capped   565/565
(100 %)
1 diff
(99.9 %id)
BF930273 nervous_tumor MTA3.o-u 2396 to 2955 31 to 589   tiling clone,   559/589
(94 %)
6 diff
(99.0 %id)
BG010964 placenta_normal MTA3.o-u 2500 to 2984 497 to 13       485/499
(97 %)
0 diff
(100 %id)
DR422648 eye, Pterygium MTA3.o-u 2908 to 3570 1 to 663   tiling clone,   663/663
(100 %)
1 diff
(99.9 %id)
AW978343   MTA3.o-u 3076 to 3782 707 to 1     Submitted on the opposite strand 707/707
(100 %)
4 diff
(99.5 %id)
T98456 liver and spleen MTA3.o-u 3115 to 3422 1 to 322       322/337
(95 %)
20 diff
(94.1 %id)
AA808189 germinal center B cell MTA3.o-u 3380 to 3790 413 to 3   tiling clone,   411/413
(99 %)
0 diff
(100 %id)
AA807232 germinal center B cell MTA3.o-u 3411 to 3512 102 to 1       102/102
(100 %)
0 diff
(100 %id)
T98512 liver and spleen MTA3.o-u 3683 to 3999 329 to 1       329/330
(99 %)
15 diff
(95.5 %id)
CV574518 cornea, eye MTA3.o-u 3732 to 4296 1 to 567 V56X     567/567
(100 %)
2 diff
(99.7 %id)
CV574795 cornea, eye MTA3.o-u 3732 to 4296 1 to 565 exact tiling clone,   565/565
(100 %)
0 diff
(100 %id)
DB344697 thymus MTA3.o-u 4152 to 4515 364 to 1   tiling clone, to resequence,   364/364
(100 %)
0 diff
(100 %id)
DB070531 testis MTA3.p-u 1 to 241 2 to 244   tiling clone, capped   243/243
(100 %)
2 diff
(99.2 %id)
BP432916   MTA3.p-u 1147 to 1503 1 to 357   tiling clone,   357/357
(100 %)
1 diff
(99.8 %id)
BM806553 melanotic melanoma, skin MTA3.p-u 1188 to 1661 1 to 479       479/926
(51 %)
16 diff
(98.3 %id)
DB340130 testis MTA3.p-u 1246 to 1797 552 to 1       552/552
(100 %)
0 diff
(100 %id)
AI732441 colon, tumor MTA3.p-u 1264 to 1800 537 to 1   tiling clone,   537/537
(100 %)
0 diff
(100 %id)
AA055766 colon, tumor MTA3.p-u 1456 to 1801 350 to 1   tiling clone,   350/351
(99 %)
4 diff
(98.9 %id)
CN357564 embryonic stem cells, DMSO-treated H9 cellline MTA3.q 1 to 756 1 to 756       756/761
(99 %)
9 diff
(98.9 %id)
CR611589 Placenta Cot 25-normalized MTA3.q 1 to 1672 1 to 1672 exact tiling clone,   1672/1672
(100 %)
0 diff
(100 %id)
AL544514 placenta, Placenta Cot 25-normalized MTA3.q 2 to 994 1 to 992   fully sequenced,   992/992
(100 %)
12 diff
(98.8 %id)
AA360448   MTA3.q 270 to 615 1 to 349       349/350
(99 %)
6 diff
(98.3 %id)
AA360449   MTA3.q 270 to 549 1 to 281       281/281
(100 %)
2 diff
(99.3 %id)
AL570616 placenta, Placenta Cot 25-normalized MTA3.q 933 to 1672 746 to 1   fully sequenced,   746/746
(100 %)
23 diff
(97.0 %id)
DA690240   MTA3.r 1 to 574 2 to 576   tiling clone, capped   575/575
(100 %)
1 diff
(99.9 %id)
DA690747   MTA3.r 21 to 593 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DB110742 thymus MTA3.r 118 to 705 2 to 588   tiling clone, capped   587/587
(100 %)
2 diff
(99.7 %id)
DB111039 thymus MTA3.r 118 to 674 2 to 559   capped   558/571
(97 %)
1 diff
(99.9 %id)
BE142714 head_neck MTA3.r 518 to 925 42 to 452 T47A tiling clone,   411/452
(90 %)
9 diff
(98.1 %id)
AW179284 stomach MTA3.s-u 8 to 557 553 to 4   tiling clone,   550/553
(99 %)
0 diff
(100 %id)
BE141432 head_neck MTA3.s-u 25 to 567 549 to 10   tiling clone, Submitted on the opposite strand 540/549
(98 %)
0 diff
(100 %id)
BE141438 head_neck MTA3.s-u 25 to 601 579 to 5     Submitted on the opposite strand 575/590
(97 %)
0 diff
(100 %id)
BE141433 head_neck MTA3.s-u 30 to 598 594 to 25     Submitted on the opposite strand 570/594
(95 %)
0 diff
(100 %id)
AW179283 stomach MTA3.s-u 33 to 532 507 to 2       506/507
(99 %)
0 diff
(100 %id)
CD657357 Embryonic Stem cells MTA3.s-u 70 to 834 7 to 768   tiling clone,   762/768
(99 %)
8 diff
(99.0 %id)
BG219747   MTA3.t 1 to 768 5 to 770 C86R N88I T89P L90S R91G ... tiling clone,   770/770
(100 %)
20 diff
(97.5 %id)
AA625440 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MTA3.t 42 to 626 1 to 584   tiling clone,   584/584
(100 %)
1 diff
(99.9 %id)
AA213752 germinal center B cell MTA3.t 213 to 629 1 to 416   tiling clone,   416/416
(100 %)
1 diff
(99.8 %id)
BI820908 pooled brain, lung, testis MTA3.u 1 to 756 3 to 762 exact tiling clone,   760/762
(99 %)
16 diff
(98.0 %id)
TI_57197094   MTA3.u 1 to 756 35 to 794 exact     760/794
(95 %)
22 diff
(97.3 %id)
BF213459 bone marrow, from acute myelogenous leukemia MTA3.va-u 1 to 665 1 to 659 F8L E9R T10R E11S S12L ... tiling clone,   659/894
(73 %)
26 diff
(97.1 %id)
DA338966 hippocampus MTA3.vb-u 1 to 594 2 to 595 exact tiling clone, capped   594/594
(100 %)
1 diff
(99.9 %id)
DA808877 brain MTA3.vc 1 to 562 2 to 563 exact tiling clone, capped   562/563
(99 %)
0 diff
(100 %id)
DA115568 cerebellum MTA3.vd 1 to 554 2 to 555 exact tiling clone, capped   554/554
(100 %)
0 diff
(100 %id)
DA974906 synovial membrane tissue from rheumatioidarthritis MTA3.ve 1 to 552 2 to 553   tiling clone, capped   552/552
(100 %)
0 diff
(100 %id)
AI733756 colon, tumor MTA3.vf-u 1 to 431 1 to 429 R10L S11L C12S P13V C14P ... tiling clone,   429/429
(100 %)
1 diff
(99.8 %id)
AW779165 pooled MTA3.vg 1 to 242 243 to 1 S20X P21S A23C L24A V25G ... tiling clone,   243/243
(100 %)
1 diff
(99.6 %id)
AA319394 adrenal gland Gene MTA3, variant not shown         Suspected internal deletion, this clone was ignored    
AK126724 cerebellum Gene MTA3, variant not shown       available from FLJ, This clone was ignored    
AW365886 head_neck Gene MTA3, variant not shown              
AW365889 head_neck Gene MTA3, variant not shown              
BE141437 head_neck Gene MTA3, variant not shown              
T82994 liver and spleen Gene MTA3, variant not shown       fully sequenced, This clone was ignored    
T90185 liver and spleen Gene MTA3, variant not shown       fully sequenced, This clone was ignored    
AA779824   Gene MTA3, variant not shown         This clone was ignored    
AA593394 Kidney, kidney tumor Gene MTA3, variant not shown         This clone was ignored    
AI371732   Gene MTA3, variant not shown         This clone was ignored    
AI933210 anaplastic oligodendroglioma, brain Gene MTA3, variant not shown         Suspected internal deletion, this clone was ignored    
CB054115 brain, glioblastoma (pooled) Gene MTA3, variant not shown         Suspected internal deletion, this clone was ignored    
CB054116 brain, glioblastoma (pooled) Gene MTA3, variant not shown         Suspected internal deletion, this clone was ignored    
BE855675 brain, glioblastoma (pooled) Gene MTA3, variant not shown         Suspected internal deletion, this clone was ignored    
BG563982 Liver Gene MTA3, variant not shown              
BM799735 eye, retinoblastoma Gene MTA3, variant not shown              
CB116317 Liver Gene MTA3, variant not shown              
DB114097 thymus Gene MTA3, variant not shown       capped      
DB343529 thymus Gene MTA3, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o-u, .p-u, .q, .r, .s-u, .t, .u, .va-u, .vb-u, .vc, .vd, .ve, .vf-u, .vg Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI